Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,769 | -67,255 | -53,905 | -40,348 | -32,505 |
| Depreciation Amortization | 633 | 2,211 | 1,626 | 1,052 | 526 |
| Accounts receivable | -5,780 | -997 | -9,011 | -12,697 | -2,787 |
| Accounts payable and accrued liabilities | 2,752 | -4,384 | -4,736 | -2,500 | -4,294 |
| Other Working Capital | -10,577 | -26,203 | -34,930 | -32,217 | -15,148 |
| Other Operating Activity | 16,464 | 63,918 | 66,582 | 53,841 | 32,594 |
| Operating Cash Flow | $-16,277 | $-32,710 | $-34,374 | $-32,869 | $-21,613 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,110 | -39,302 | -87,913 | -99,645 | -94,961 |
| PPE Investments | -546 | -13,672 | -12,564 | -10,208 | -7,312 |
| Purchase Sale Intangibles | -1 | -337 | -337 | -484 | -287 |
| Other Investing Activity | -159 | -163 | -122 | -421 | -282 |
| Investing Cash Flow | $-2,815 | $-53,137 | $-100,599 | $-110,275 | $-102,556 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -9 | -91 | -82 | -66 | -38 |
| Common Stock Issued | 292 | 576 | 513 | 349 | 322 |
| Other Financing Activity | -1 | 0 | -1 | 1 | -1 |
| Financing Cash Flow | $282 | $485 | $430 | $285 | $284 |
| Exchange Rate Effect | 1,549 | -2,181 | 366 | -6,522 | -12,742 |
| Beginning Cash Position | 254,568 | 342,111 | 342,111 | 354,963 | 346,667 |
| End Cash Position | 237,307 | 254,568 | 207,933 | 205,583 | 210,042 |
| Net Cash Flow | $-17,260 | $-87,543 | $-134,177 | $-149,381 | $-136,626 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,277 | -32,710 | -34,374 | -32,869 | -21,613 |
| Capital Expenditure | -546 | -13,696 | -12,564 | -10,208 | -7,312 |
| Free Cash Flow | -16,823 | -46,406 | -46,938 | -43,077 | -28,925 |